- Home
- AVAH vs PRAX Comparison
AVAH vs PRAX Comparison
Compare AVAH & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVAH
- PRAX
- Stock Information
- Founded
- AVAH 1984
- PRAX 2015
- Country
- AVAH United States
- PRAX United States
- Employees
- AVAH N/A
- PRAX N/A
- Industry
- AVAH Hospital/Nursing Management
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- AVAH Health Care
- PRAX Health Care
- Exchange
- AVAH Nasdaq
- PRAX Nasdaq
- Market Cap
- AVAH 872.6M
- PRAX 950.8M
- IPO Year
- AVAH 2021
- PRAX 2020
- Fundamental
- Price
- AVAH $8.41
- PRAX $38.31
- Analyst Decision
- AVAH Buy
- PRAX Strong Buy
- Analyst Count
- AVAH 5
- PRAX 9
- Target Price
- AVAH $7.50
- PRAX $94.44
- AVG Volume (30 Days)
- AVAH 1.3M
- PRAX 402.3K
- Earning Date
- AVAH 11-06-2025
- PRAX 11-05-2025
- Dividend Yield
- AVAH N/A
- PRAX N/A
- EPS Growth
- AVAH N/A
- PRAX N/A
- EPS
- AVAH 0.09
- PRAX N/A
- Revenue
- AVAH $2,177,672,000.00
- PRAX $7,765,000.00
- Revenue This Year
- AVAH $16.37
- PRAX N/A
- Revenue Next Year
- AVAH $6.62
- PRAX $25.00
- P/E Ratio
- AVAH $87.18
- PRAX N/A
- Revenue Growth
- AVAH 11.54
- PRAX 338.45
- 52 Week Low
- AVAH $3.67
- PRAX $26.70
- 52 Week High
- AVAH $8.45
- PRAX $91.83
- Technical
- Relative Strength Index (RSI)
- AVAH 78.33
- PRAX 29.96
- Support Level
- AVAH $8.05
- PRAX $37.19
- Resistance Level
- AVAH $8.41
- PRAX $40.69
- Average True Range (ATR)
- AVAH 0.32
- PRAX 2.33
- MACD
- AVAH -0.06
- PRAX -0.73
- Stochastic Oscillator
- AVAH 91.82
- PRAX 9.42
About AVAH Aveanna Healthcare Holdings Inc.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.